These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20211659)

  • 1. Granins and granin-related peptides in neuroendocrine tumours.
    Portela-Gomes GM; Grimelius L; Wilander E; Stridsberg M
    Regul Pept; 2010 Nov; 165(1):12-20. PubMed ID: 20211659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
    Portela-Gomes GM; Grimelius L; Stridsberg M
    Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors.
    Conlon JM
    Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system.
    Helle KB
    Results Probl Cell Differ; 2010; 50():21-44. PubMed ID: 20217490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
    Nunzi MG; Mugnaini E
    Neuroscience; 2009 Sep; 162(3):673-87. PubMed ID: 19217926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins.
    Le Gall F; Vallet VS; Thomas D; De Monti M; Duval J; Ramee MP
    Pathol Res Pract; 1997; 193(3):179-85. PubMed ID: 9198103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.
    Portela-Gomes GM; Grimelius L; Stridsberg M
    Cell Mol Neurobiol; 2010 Nov; 30(8):1147-53. PubMed ID: 21046454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Janson ET
    Regul Pept; 2008 Jun; 148(1-3):95-8. PubMed ID: 18448176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.
    Feldman SA; Eiden LE
    Endocr Pathol; 2003; 14(1):3-23. PubMed ID: 12746559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.
    Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L
    Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A.
    Hendy GN; Bevan S; Mattei MG; Mouland AJ
    Clin Invest Med; 1995 Feb; 18(1):47-65. PubMed ID: 7768066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours.
    Ferrari L; Seregni E; Bajetta E; Martinetti A; Bombardieri E
    Anticancer Res; 1999; 19(4C):3415-27. PubMed ID: 10629629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into granin-derived peptides: evolution and endocrine roles.
    Zhao E; Zhang D; Basak A; Trudeau VL
    Gen Comp Endocrinol; 2009; 164(2-3):161-74. PubMed ID: 19523383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranins A and B and secretogranin II: evolutionary and functional aspects.
    Montero-Hadjadje M; Vaingankar S; Elias S; Tostivint H; Mahata SK; Anouar Y
    Acta Physiol (Oxf); 2008 Feb; 192(2):309-24. PubMed ID: 18005393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions.
    Helle KB
    Regul Pept; 2010 Nov; 165(1):45-51. PubMed ID: 19800929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granin-derived peptides.
    Troger J; Theurl M; Kirchmair R; Pasqua T; Tota B; Angelone T; Cerra MC; Nowosielski Y; Mätzler R; Troger J; Gayen JR; Trudeau V; Corti A; Helle KB
    Prog Neurobiol; 2017 Jul; 154():37-61. PubMed ID: 28442394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
    Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
    Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
    Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
    Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
    Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
    APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.